Evidence map›Paper›PMID 28634229›Full record

ArticleThe Journal of biological chemistry2017

Akt activation by Ca

Angela M Gocher, Gissou Azabdaftari, Lindsey M Euscher, Shuhang Dai, Loukia G Karacosta, Thomas F Franke, Arthur M Edelman

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 117 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Dual-action peptide KWHVeterinary research · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Angela M GocherFrom the Department of Pharmacology and Toxicology, State University of New York at Buffalo, Buffalo, New York 14214.
Gissou AzabdaftariDepartment of Pathology and Laboratory Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263.
Lindsey M EuscherFrom the Department of Pharmacology and Toxicology, State University of New York at Buffalo, Buffalo, New York 14214.
Shuhang DaiFrom the Department of Pharmacology and Toxicology, State University of New York at Buffalo, Buffalo, New York 14214.
Loukia G KaracostaFrom the Department of Pharmacology and Toxicology, State University of New York at Buffalo, Buffalo, New York 14214.
Thomas F FrankeDepartment of Psychiatry, Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York 10016.
Arthur M EdelmanFrom the Department of Pharmacology and Toxicology, State University of New York at Buffalo, Buffalo, New York 14214,. Electronic address: aedelman@buffalo.edu.
University at Buffalo, State University of New York · USNew York University · USRoswell Park Comprehensive Cancer Center · US

Funding

Restoring Biospecimen Research Resources Lost Due to Super Storm SandyR24OD018340 · OD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LEVY, DAVID E · 2014 to 2014
$2.5M
NIH HHS R24 OD018340
6 · The paper itself

Abstract

Hyperactivation of Akt is associated with oncogenic changes in the growth, survival, and chemoresistance of cancer cells. The PI3K/phosphoinositide-dependent kinase (PDK) 1 pathway represents the canonical mechanism for phosphorylation of Akt at its primary activation site, Thr-308. We observed that Ca

Indexed as

Calcium SignalingProtein Processing, Post-TranslationalAntineoplastic AgentsApoptosisCalcium-Calmodulin-Dependent Protein Kinase KinaseCell Line, TumorCell ProliferationCell SurvivalEnzyme ActivationFemaleG1 PhaseGene Expression Regulation, NeoplasticHumansNeoplasm GradingNeoplasm ProteinsOvarian NeoplasmsAKT1 protein, humanAntineoplastic AgentsCalcium-Calmodulin-Dependent Protein Kinase KinaseCAMKK2 protein, humanNeoplasm ProteinsProtein Kinase InhibitorsProto-Oncogene Proteins c-aktRecombinant ProteinsAkt PKBcalmodulin (CaM)ovarian cancerphosphorylationprotein kinase

Identifiers

PMID28634229
PMCPMC5572912
OpenAlexW2673491502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.